NCT04526600 Fidgeting and Attentional and Emotional Regulation in ADHD
| NCT ID | NCT04526600 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Davis |
| Condition | ADHD |
| Study Type | INTERVENTIONAL |
| Enrollment | 109 participants |
| Start Date | 2022-03-21 |
| Primary Completion | 2024-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 109 participants in total. It began in 2022-03-21 with a primary completion date of 2024-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project will study how fidgeting relates to cognitive and emotional functioning in adults with attention-deficit/hyperactivity disorder (ADHD). It will determine, in a laboratory setting, whether movement and access to a "fidget device" providing sensory and motor stimulation can improve cognitive and emotional regulation (including on physiological measures) in adult ADHD. The investigators will also acquire pilot data for machine learning analyses to be used in future, large scale studies to identify gestures and touch characteristics associated with improved cognitive and emotional regulation to see if the data can predict and subsequently develop recommendations to improve performance and emotional control in natural settings (e.g., home, office, college classroom) for adult ADHD.
Eligibility Criteria
Inclusion Criteria: * ADHD * History of fidgeting Exclusion Criteria: * Currently taking psychoactive medication, with the exception of stimulant medication for ADHD or medication that can affect heart rate; * Presence of significant depression or psychotic disorders, autism, visual or hearing impairment or any other disorder that may interfere with task performance; and IQ below 85
Contact & Investigator
Julie Schweitzer, Ph.D.
PRINCIPAL INVESTIGATOR
UC Davis MIND Institute
Frequently Asked Questions
Who can join the NCT04526600 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 30 Years, studying ADHD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04526600 currently recruiting?
Yes, NCT04526600 is actively recruiting participants. Contact the research team at jborden@ucdavis.edu for enrollment information.
Where is the NCT04526600 trial being conducted?
This trial is being conducted at Sacramento, United States.
Who is sponsoring the NCT04526600 clinical trial?
NCT04526600 is sponsored by University of California, Davis. The principal investigator is Julie Schweitzer, Ph.D. at UC Davis MIND Institute. The trial plans to enroll 109 participants.